Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.

Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.

Chronic inflammation closely associates with obesity, metabolic syndrome, diabetes mellitus, and atherosclerosis. Evidence indicates that the immunomodulator pentraxin 3 (PTX3) may serve as a biomarker of these cardiometabolic disorders, but whether PTX3 predicts cardiovascular complications is unkn...

Full description

Bibliographic Details
Main Authors:	Tetsuro Miyazaki, Stephanie Chiuve, Frank M Sacks, Paul M Ridker, Peter Libby, Masanori Aikawa
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3976379?pdf=render

Similar Items

Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation
by: Liu Haibo, et al.
Published: (2014-01-01)

Serum Pentraxin 3 A Marker in Diagnosing Acute Coronary Syndrome
by: K Vanitha, et al.
Published: (2016-10-01)

Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease
by: Lauren L. Ching, et al.
Published: (2020-06-01)

Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease
by: Toshiyuki Kitoh, et al.
Published: (2021-04-01)

ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease
by: Zhen Wang, et al.
Published: (2019-01-01)

Association of serum pentraxin-3 and high-sensitivity C-reactive protein with the extent of coronary stenosis in patients undergoing coronary angiography
by: Vuković-Dejanović Vesna, et al.
Published: (2015-01-01)

Cardiohemodynamics Features and Coronary Artery Injury in Patients with Coronary Artery Disease and Comorbide Diabetes Mellitus Type 2 Depending on the Activity of Immune Inflammation Based on the Study of Pentraxin-3 Indicators in Blood Serum
by: Molotiagin D., et al.
Published: (2020-04-01)

Plasma Proteome Profiling of Coronary Artery Disease Patients: Downregulation of Transthyretin—An Important Event
by: null Monu, et al.
Published: (2020-01-01)

Metabolic syndrome and coronary artery disease
by: Manuela Fiuza
Published: (2012-12-01)

Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow
by: Muhammad Diah, et al.
Published: (2019-10-01)

Diagnostic and Prognostic Significance of Neutrophil Gelatinase- Associated Lipocalin and Pentraxin-3 in Acute Coronary Syndrome
by: Muhammet Raşit Özer, et al.
Published: (2017-03-01)

The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease1s⃞
by: Guenther Silbernagel, et al.
Published: (2009-02-01)

Evaluation of pentraxin-3 level and its related factors in patients undergoing primary percutaneous coronary intervention
by: Saeed Alipour-Parsa, et al.
Published: (2017-05-01)

Identification of the genetic determinants of premature coronary artery events
by: Durham, Nigel Philip
Published: (2004)

Association of metabolic syndrome with severity of coronary artery disease
by: Namita Mahalle, et al.
Published: (2014-01-01)

Impact of prior cerebrovascular events on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or percutaneous coronary intervention
by: Yu Pan, et al.
Published: (2021-08-01)

Predictors of adverse cardiovascular events in patients with coronary artery disease after percutaneous coronary intervention
by: A. V. Svarovskaya, et al.
Published: (2020-07-01)

Carbohydrate metabolism disorders and coronary collateral circulation in patients with chronic coronary artery disease
by: Ivan Vasil'evich Starostin, et al.
Published: (2015-04-01)

Metabolic Alterations Identified in Urine, Plasma and Aortic Smooth Muscle Cells Reflect Cardiovascular Risk in Patients with Programmed Coronary Artery Bypass Grafting
by: Aranzazu Santiago-Hernandez, et al.
Published: (2021-08-01)

Recent hospitalization for Non-coronary events and use of preventive medications for coronary artery disease: An observational cohort study
by: Maddox Thomas M, et al.
Published: (2011-07-01)

Plasminogen and fibrinogen plasma levels in coronary artery disease
by: Luciana Moreira Lima, et al.
Published: (2012-01-01)

Plasminogen and fibrinogen plasma levels in coronary artery disease
by: Rashid S. Kazmi, et al.
Published: (2012-01-01)

Significance of Coronary Calcification for Prediction of Coronary Artery Disease and Cardiac Events Based on 64-Slice Coronary Computed Tomography Angiography
by: Yuan-Chang Liu, et al.
Published: (2013-01-01)

CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology.
by: Christian Erbel, et al.
Published: (2015-01-01)

CORONARY ARTERY ANOMALY. CORONARY-PULMONARY FISTULA
by: S. V. Topilina, et al.
Published: (2019-04-01)

Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease
by: O. A. Koshelskaya, et al.
Published: (2020-03-01)

Coronary Arterial Stenting in Acute Coronary Syndrome
by: S. O. Sokolova, et al.
Published: (2006-02-01)

Giant coronary artery aneurysms involving all three coronary arteries
by: J. Veenu, et al.
Published: (2014-11-01)

Early results of coronary artery bypass grafting with coronary endarterectomy for severe coronary artery disease
by: Toischer Karl, et al.
Published: (2009-09-01)

Coronary Artery Disease Risk Factors, Coronary Artery Calcification and Coronary Bypass Surgery
by: Fatih Rifat Ulusoy, et al.
Published: (2015-05-01)

Coronary artery fistulas
by: V. M. Subbotin, et al.
Published: (2016-03-01)

Interrelationship of Carbohydrate and Lipid Metabolism in Coronary Artery Disease
by: Ghosh, P.
Published: (1975)

Correlation Between Metabolic Syndrome and Coronary Artery Calcification
by: Kuo-Chi Lin, et al.
Published: (2015)

The coronary arteri
by: Mohamed Talaat, et al.
Published: (2016-12-01)

Predictors of cardiac arrhythmic events in non coronary artery disease patients
by: C. Balla, et al.
Published: (2019-05-01)

Percutaneous Coronary Intervention of Hidden Coronary Artery-Unusual Type of Isolated Single Coronary Artery
by: Shivanand Patil, et al.
Published: (2016-08-01)

Relationship of Serum Pentraxin-3 with Peripheral Arterial Disease
by: Burak Katipoglu, et al.
Published: (2018-12-01)

Dual anterior descending coronary artery associated with coronary artery disease
by: Siqueira Luciane da L. V., et al.
Published: (2003-01-01)

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease
by: Xiao-hong Zhou, et al.
Published: (2020-05-01)

Plasma haptoglobin concentrations are elevated in patients with coronary artery disease.
by: Ching-Wei Lee, et al.
Published: (2013-01-01)